Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
grade C 156.67 1.82% 2.80
DXCM closed up 1.82 percent on Thursday, October 17, 2019, on 64 percent of normal volume. It ran into resistance at its 50 day moving average.

Earnings due: Nov 7

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Up
See historical DXCM trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
20 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Inside Day Range Contraction 0.00%
50 DMA Resistance Bearish 1.82%
Crossed Above 20 DMA Bullish 1.82%
Calm After Storm Range Contraction 1.82%
Fell Below 20 DMA Bearish 2.42%
Fell Below 50 DMA Bearish 2.42%
Hammer Candlestick Bullish 2.42%

Older signals for DXCM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Medical Monitoring Endocrinology Software Platform Blood Glucose Monitoring Continuous Glucose Monitor Hyperglycemia Hypoglycemia
Is DXCM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 178.35
52 Week Low 105.05
Average Volume 794,185
200-Day Moving Average 141.6917
50-Day Moving Average 158.1786
20-Day Moving Average 153.8685
10-Day Moving Average 155.763
Average True Range 6.3307
ADX 15.51
+DI 20.8968
-DI 24.2791
Chandelier Exit (Long, 3 ATRs ) 143.1479
Chandelier Exit (Short, 3 ATRs ) 164.5921
Upper Bollinger Band 161.1828
Lower Bollinger Band 146.5542
Percent B (%b) 0.69
BandWidth 9.507209
MACD Line -0.0728
MACD Signal Line -0.5394
MACD Histogram 0.4665
Fundamentals Value
Market Cap 13.57 Billion
Num Shares 86.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -206.14
Price-to-Sales 6.08
Price-to-Book 10.87
PEG Ratio -1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 163.75
Resistance 3 (R3) 163.56 161.01 162.57
Resistance 2 (R2) 161.01 159.21 161.11 162.18
Resistance 1 (R1) 158.84 158.09 159.93 159.03 161.78
Pivot Point 156.29 156.29 156.83 156.39 156.29
Support 1 (S1) 154.12 154.49 155.21 154.31 151.56
Support 2 (S2) 151.57 153.37 151.67 151.16
Support 3 (S3) 149.40 151.57 150.77
Support 4 (S4) 149.59